Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: J Sleep Res. 2010 Apr 7;19(3):384–393. doi: 10.1111/j.1365-2869.2010.00833.x

Fig. 3.

Fig. 3

Effects of Esz treatment, compared to Veh, on hippocampal cell survival (A) and proliferation (B). Cell survival was assessed 33 days after the first of 3 daily BrdU injections. Esz was administered twice daily for 14 days after BrdU injections. The total number of BrdU-labeled cells was increased by 46% (P<0.008). Cell proliferation was assessed by counting BrdU-labeled cells following seven days Esz treatment; BrdU was administered on days 3, 5, and 7. Significant changes in proliferation were not found. (Survival study: N=8 for both Esz and Veh groups. Proliferation study; N=6 in both groups.)